Investors

Verastem, Inc. (NASDAQ:VSTM) is a clinical-stage biopharmaceutical company focused on developing therapies to improve the lives of patients diagnosed with cancer in ways that are truly meaningful to them. Our product candidates seek to treat cancer by targeting malignant cells both directly and through modulation of the tumor microenvironment.